Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BULLETIN
January 31, 2005
- EPMA to Propose "Reference Drug Benefit System": Mr Yoshida
January 31, 2005
- EDITOR'S NOTE
January 31, 2005
- Toho Ties Up with Itochu for SPD
January 31, 2005
- MEDICAL DEVICE NEWS IN BRIEF
January 31, 2005
- BUSINESS NEWS IN BRIEF -1-
January 31, 2005
- Local Gov't Officers Discuss Challenges in Healthcare
January 31, 2005
- NEW PRODUCTS
January 31, 2005
- BUSINESS NEWS IN BRIEF -2-
January 31, 2005
- WEBSITE NEWS
January 31, 2005
- Korosho to Promote Clinical Trials of Drugs Unapproved in Japan: Dr Iwao
January 31, 2005
- Annual Business Results
January 31, 2005
- BULLETIN
January 31, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 31, 2005
- R&D Spending by Pharma Industry Fell 8.5% in FY2003
January 31, 2005
- Iryo Proverbs Reveal Japanese Spirit (25)
January 31, 2005
- Committees to Evaluate Efficacy of Drugs Questioned in EBM-based GL
January 24, 2005
- JPMA to Start Full-Scale Discussions on New Drug Pricing
January 24, 2005
- PMDA's Performance in 1st Half of FY2004 Announced
January 24, 2005
- BUSINESS NEWS IN BRIEF
January 24, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…